UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4245) 4245
Book Chapter (31) 31
Newsletter (16) 16
Magazine Article (9) 9
Dissertation (6) 6
Newspaper Article (5) 5
Conference Proceeding (2) 2
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2788) 2788
life sciences & biomedicine (2656) 2656
humans (2283) 2283
male (2079) 2079
animals (2018) 2018
female (1554) 1554
benzoates - administration & dosage (1312) 1312
benzoates - pharmacology (1276) 1276
benzoates - therapeutic use (1188) 1188
biological and medical sciences (999) 999
rats (968) 968
medical sciences (855) 855
pharmacology & pharmacy (807) 807
adult (720) 720
middle aged (687) 687
mice (579) 579
pharmacology. drug treatments (491) 491
aged (471) 471
benzoates - adverse effects (466) 466
treatment outcome (412) 412
dose-response relationship, drug (408) 408
administration, oral (403) 403
telmisartan (391) 391
time factors (390) 390
benzimidazoles - administration & dosage (374) 374
benzimidazoles - therapeutic use (361) 361
hematology (332) 332
benzoates (317) 317
rats, sprague-dawley (314) 314
hypertension - drug therapy (309) 309
adolescent (303) 303
benzoates - pharmacokinetics (298) 298
analysis (293) 293
abridged index medicus (291) 291
blood pressure - drug effects (278) 278
chemistry (276) 276
benzimidazoles - pharmacology (271) 271
benzoates - chemistry (268) 268
cardiovascular system & cardiology (255) 255
drug therapy, combination (252) 252
rats, wistar (250) 250
hypertension (249) 249
physical sciences (248) 248
triazoles - therapeutic use (233) 233
disease models, animal (232) 232
benzoic acid (230) 230
sodium benzoate (229) 229
biochemistry & molecular biology (228) 228
child (225) 225
iron chelating agents - therapeutic use (216) 216
oncology (214) 214
neurosciences & neurology (209) 209
fundamental and applied biological sciences. psychology (208) 208
research (208) 208
neurosciences (200) 200
triazoles - administration & dosage (194) 194
angiotensin ii type 1 receptor blockers - therapeutic use (193) 193
benzoates - metabolism (193) 193
deferasirox (192) 192
pyrazoles - therapeutic use (191) 191
health aspects (186) 186
iron overload - drug therapy (183) 183
care and treatment (182) 182
double-blind method (182) 182
hydrazines - therapeutic use (182) 182
drug therapy (181) 181
angiotensin ii type 1 receptor blockers - administration & dosage (178) 178
toxicology (178) 178
peripheral vascular disease (173) 173
iron chelating agents - administration & dosage (170) 170
drug combinations (162) 162
medicine & public health (160) 160
young adult (159) 159
angiotensin ii type 1 receptor blockers - pharmacology (157) 157
child, preschool (156) 156
rodents (153) 153
estradiol - pharmacology (150) 150
antihypertensive agents - administration & dosage (147) 147
antihypertensive agents - therapeutic use (146) 146
receptors, thrombopoietin - agonists (146) 146
mice, inbred c57bl (144) 144
pyrazoles - administration & dosage (141) 141
estradiol benzoate (140) 140
monoterpenes (137) 137
purpura, thrombocytopenic, idiopathic - drug therapy (137) 137
medicine, research & experimental (134) 134
research & experimental medicine (133) 133
hydrazines - administration & dosage (131) 131
liver - metabolism (131) 131
aged, 80 and over (130) 130
eltrombopag (130) 130
pregnancy (128) 128
cell biology (127) 127
cells, cultured (126) 126
risk factors (126) 126
general & internal medicine (125) 125
endocrinology & metabolism (124) 124
benzoates - blood (123) 123
general pharmacology (122) 122
internal medicine (122) 122
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4026) 4026
German (104) 104
Japanese (103) 103
Russian (61) 61
French (41) 41
Chinese (35) 35
Italian (19) 19
Spanish (16) 16
Portuguese (9) 9
Polish (8) 8
Dutch (7) 7
Czech (4) 4
Danish (4) 4
Hungarian (3) 3
Bulgarian (2) 2
Norwegian (2) 2
Romanian (2) 2
Swedish (2) 2
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer cell, ISSN 1535-6108, 07/2015, Volume 28, Issue 1, pp. 57 - 69
Journal Article
Seminars in oncology, ISSN 0093-7754, 10/2011, Volume 38, Issue 5, pp. 635 - 647
Life Sciences & Biomedicine | Oncology | Science & Technology | Recombinant Proteins - therapeutic use | Benzoates - adverse effects | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Erythropoietin - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Erythropoietin - adverse effects | Thrombopoietin - therapeutic use | Recombinant Proteins - adverse effects | Thrombopoietin - administration & dosage | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Filgrastim | Patient Selection | Receptors, Fc - therapeutic use | Erythropoietin - analogs & derivatives | Drug-Related Side Effects and Adverse Reactions | Colony-Stimulating Factors - adverse effects | Epoetin Alfa | Hydrazines - administration & dosage | Myelodysplastic Syndromes - drug therapy | Recombinant Fusion Proteins - administration & dosage | Colony-Stimulating Factors - therapeutic use | Pyrazoles - adverse effects | Granulocyte Colony-Stimulating Factor - adverse effects | Erythropoietin - administration & dosage | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Hydrazines - therapeutic use | Hematinics - therapeutic use | Polyethylene Glycols | Hematinics - adverse effects | Granulocyte Colony-Stimulating Factor - therapeutic use | Hematinics - administration & dosage | Recombinant Proteins - administration & dosage | Benzoates - administration & dosage | Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects | Pyrazoles - administration & dosage | Thrombopoietin - adverse effects | Receptors, Fc - administration & dosage | Darbepoetin alfa | Colony-Stimulating Factors - administration & dosage | Granulocyte Colony-Stimulating Factor - administration & dosage | Hydrazines - adverse effects
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2018, Volume 320, Issue 6, pp. 566 - 579
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 12/2007, Volume 176, Issue 11, pp. 1138 - 1145
BAY 41-2272 | BAY 58-2667 | Pulmonary hypertension | BAY 41-8543 | Soluble guanylate cyclase | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pharmacology. Drug treatments | Biological and medical sciences | Intensive care medicine | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Respiratory system | Pneumology | Oxadiazoles - administration & dosage | Injections, Intravenous | Nitric Oxide - pharmacology | Purinones - administration & dosage | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Oxadiazoles - pharmacology | Lung - metabolism | Pyrazoles - pharmacology | Powders | Pyridines - administration & dosage | Quinoxalines - administration & dosage | Pyrimidines - administration & dosage | Morpholines - administration & dosage | Administration, Inhalation | Morpholines - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Soluble Guanylyl Cyclase | Receptors, Cytoplasmic and Nuclear - agonists | Pyrimidines - pharmacology | Nitric Oxide - administration & dosage | Benzoates - administration & dosage | Particle Size | Phosphodiesterase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Animals | Cyclic GMP - metabolism | Guanylate Cyclase | Lung - drug effects | Aerosols | Benzoates - pharmacology | Purinones - pharmacology | Sheep | Pulmonary Circulation - drug effects | Pyridines - pharmacology | Vasodilation - drug effects | Drug Combinations | Index Medicus | Abridged Index Medicus | H. Pulmonary Vascular Disease | soluble guanylate cyclase | pulmonary hypertension
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Journal Article